OCS earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E -5.38. Updated 2026-07-23.
Oculis Holding (OCS) Research Hub
Oculis Holding (OCS) trades on NASDAQ, CH in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 7.96 USD (+0.76%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.38, market cap 0.66B. This hub links to the full technical, earnings and options research available for OCS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CH |
| Last close | 7.96 USD (+0.76%) |
| 52-week range | 7.11 USD – 14.35 USD |
| Trend regime | Range |
| 14-day RSI | 38.3 (Bearish) |
| Trailing P/E | -5.38 |
| Market cap | 0.66B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for OCS
Covered Call on OCS: how it works, illustrative setup around the real 7.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on OCS: how it works, illustrative setup around the real 7.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on OCS: how it works, illustrative setup around the real 7.96 USD price, max profit/loss, breakeven and when to use it. Educational.
OCS technical analysis: range, last 7.96 USD, RSI 38.3, 52w range 7.11 USD–14.35 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is OCS in?
Oculis Holding (OCS) is classified under Healthcare (Biotechnology), listed on NASDAQ, CH.
Is OCS in an uptrend or downtrend?
As of 2026-10-26, OCS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is OCS's trailing P/E ratio?
OCS's trailing P/E is -5.38, with a market cap of 0.66B. See the earnings research page for full valuation detail.
When does OCS next report earnings?
OCS is next scheduled to report earnings on 2026-08-06.